Does Ketamine Therapy Actually Work? What the Evidence Says

Short answer: For many people, yes, and the evidence behind it is why ketamine has drawn so much attention in psychiatry. In studies of treatment-resistant depression, a majority of patients respond to a course of ketamine, often within hours to days rather than weeks. It is not a cure and not everyone benefits, but for people whom standard treatments have failed, the research is encouraging. Here is a fair reading of it.

What the studies show

Ketamine's rapid antidepressant effect has been examined in randomized controlled trials for over two decades, and the findings have been repeatedly confirmed: low-dose ketamine can lift depressive symptoms quickly, including in people with severe, treatment-refractory depression. Response rates in studies of IV ketamine for treatment-resistant depression commonly land in the range of one half to two thirds of patients, which is remarkable in a population that has already failed multiple treatments. Research has also found meaningful reductions in hopelessness and suicidal thinking for many patients.

Why the speed matters

Traditional antidepressants typically take four to six weeks to show benefit, and each failed trial means more weeks of waiting. Ketamine works through a different mechanism, acting on the brain's glutamate system and promoting new connections between neurons, and its effects often appear within hours to days. For someone in a deep hole, that difference is not a detail. It changes what the next two weeks of life look like, which is part of why the FDA approved ketamine's cousin esketamine for treatment-resistant depression. You can go deeper in our post on how ketamine works in the brain.

The honest limits

A trustworthy answer includes what ketamine does not do. Roughly a third or more of patients do not respond meaningfully. The benefits of a single infusion usually fade within days to weeks, which is why treatment is a series followed by maintenance rather than a one-time fix. The research base, while substantial and growing, is younger than the decades of data behind older treatments, and clinical use has grown faster than the published evidence in some respects. None of this undermines the genuine promise; it just frames it honestly.

Who tends to benefit most

The strongest evidence is in treatment-resistant depression, meaning depression that has not responded adequately to standard treatments. There is also encouraging research in anxiety, PTSD, OCD, and certain chronic pain conditions. If you have tried therapy and one or more medications without enough relief, you are in the group where ketamine has the most to offer. Our post on what is treatment-resistant depression covers this in detail.

How we think about it at Ketamine Uplift

We are honest with people about odds. Most of our patients respond, some profoundly, and a minority do not, which is why Dr. O'Neill evaluates every person before recommending a course and tracks response throughout. An honest yes is worth more than an inflated one.

This article is for educational purposes only and is not medical advice. Outcomes vary from person to person.

The bottom line

Does ketamine therapy work? For a majority of people with hard-to-treat depression in clinical studies, yes, and often quickly. It is not universal and not permanent without maintenance, but as an evidence-backed option for people who have run out of standard answers, it has earned its place. If you want to talk through whether it is likely to help you, call us at (310) 280-4440.

Frequently asked questions

What percentage of people respond to ketamine therapy? In studies of treatment-resistant depression, response rates commonly fall between one half and two thirds of patients, which is notable in a group that has already failed multiple treatments.

How fast does ketamine therapy work? Many people notice improvement within hours to days of an infusion, compared with the four to six weeks typical of standard antidepressants.

Does ketamine work for everyone? No. A meaningful minority of patients do not respond, and benefits fade without maintenance. A proper evaluation helps set honest expectations before you commit.

Is ketamine therapy backed by real research? Yes. Its rapid antidepressant effect has been demonstrated in randomized controlled trials over more than two decades, and the FDA approved the related medication esketamine for treatment-resistant depression in 2019.